EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 101 | -35.7% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 157 | -30.8% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 227 | -6.6% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 243 | +21.5% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 200 | -5.7% | 0.00% | – |
| Q2 2021 | $13,000 | -27.8% | 212 | +6.0% | 0.00% | – |
| Q1 2021 | $18,000 | -74.6% | 200 | -75.0% | 0.00% | -100.0% |
| Q4 2020 | $71,000 | -24.5% | 800 | -12.9% | 0.00% | 0.0% |
| Q3 2020 | $94,000 | +23.7% | 919 | -4.6% | 0.00% | 0.0% |
| Q2 2020 | $76,000 | +192.3% | 963 | +112.6% | 0.00% | – |
| Q1 2020 | $26,000 | +136.4% | 453 | +112.7% | 0.00% | – |
| Q4 2019 | $11,000 | 0.0% | 213 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | 0.0% | 213 | -6.2% | 0.00% | – |
| Q2 2019 | $11,000 | -38.9% | 227 | -37.5% | 0.00% | – |
| Q1 2019 | $18,000 | – | 363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |